celtrix
pharmaceuticals
friday
said
raised
14
million
private
equity
placement
various
unnamed
foreign
institutional
investors.celtrix
expects
use
funds
primarily
advance
clinical
development
lead
compound
somatokine
r
general
corporate
purposes
including
product
manufacturing
working
capital.the
private
placement
consisted
approximately
5.7
million
shares
celtrix
common
stock
priced
current
fair
market
value
year
stock
purchase
warrants
